Cytokines and JAK-STAT signaling

Experimental Cell Research

Volumn 253, Issue 1, 1999, Pages 7-14

  Schindler, Christian ^a  

^a HHSC 1212 ^*  (United States)

Author keywords

Cytokine; Cytokine signaling; JAK; STAT

Indexed keywords

ALPHA INTERFERON; CYTOKINE; GAMMA INTERFERON; PROTEIN KINASE; STAT1 PROTEIN; STAT2 PROTEIN; STAT3 PROTEIN; STAT4 PROTEIN; STAT5 PROTEIN; STAT6 PROTEIN;

CELL COMMUNICATION; EUKARYOTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN STRUCTURE; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION;

EID: 0033604579     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.1999.4670     Document Type: Article

References (69)

1. Bazan J. F. Shared architecture of hormone binding domains in type I and II interferon receptors. Cell. 61:1990;753-754.
2. Schindler C., Strehlow I. Cytokines and STAT signaling. O'Malley B. W. Advances in Pharmacology. 1999;113-173 Academic Press, San Diego.
3. Lemmon M. A., Schlessinger J. Regulation of signal transduction and signal diversity by receptor oligomerization. Trends Biochem. Sci. 19:1994;459-463.
4. Ihle J. Cytokine receptor signaling. Nature. 377:1995;591-594.
5. Ihle J. N. STATs: Signal transducers and activators of transcription. Cell. 84:1996;331-334.
6. Darnell J. E. STATs and gene regulation. Science. 277:1997;1630-1635.
7. Pestka S. The human interferon alpha species and hybrid proteins. Semin. Oncol. 24:1997;S9-4-S9-17.
8. Bach E. A., Aguet M., Schreiber R. D. The IFN gamma receptor: A paradigm for cytokine receptor signaling. Annu. Rev. Immunol. 15:1997;563-591.
9. Schindler C., Fu X.-Y., Improta T., Aebersold R., Darnell J. E. Proteins of transcription factor ISGF-3: One gene encodes the 91- and 84-kDa ISGF-3 proteins that are activated by interferon alpha. Proc. Natl. Acad. Sci. USA. 89:1992;7836-7839.
10. Schindler C., Shuai K., Prezioso V., Darnell J. E. Interferon-dependent tyrosine phosphorylation of a latent cytoplasmic transcription factor. Science. 257:1992;809-813.
11. Müller M., Briscoe J., Laxton C., Guschin D., Ziemiecki A., Silvennoinen O. The protein tyrosine kinase Jak-1 complements defects in the Interferon-α/β and -γ signal transduction pathways. Nature. 366:1993;129-135.
12. Velazquez L., Fellous M., Stark G. R., Pellegrini S. A protein tyrosine kinase in the interferon α/β signaling pathway. Cell. 70:1992;313-322.
13. Decker T., Kovarik P., Meinke A. GAS elements: A few nucleotides with a major impact on cytokine-induced gene expression. J. Interferon Cytokine Res. 17:1997;121-134.
14. Chen X., Winkemeier U., Zhao Y., Jeruzalmi D., Darnell J. E., Kuriyan J. Crystal structure of a tyrosine phosphorylated Stat1 dimer bound to DNA. Cell. 93:1998;827-839.
15. Becker S., Groner B., Müller C. W. Three-dimensional structure of the Stat3β homodimer bound to DNA. Nature. 394:1998;145-151.
16. Vinkemeier U., Moarefi I., Darnell J. E., Kuriyan J. Structure of the amino-terminal protein interaction domain of Stat-4. Science. 279:1998;1048-1052.
17. Pellegrini S., Dusanter-Fourt I. The structure, regulation and function of the Janus kinases (JAKs) and the signal transducers and activators of transcription (STATs). Eur. J. Biochem. 248:1997;615-633.
18. Rodig S. J., Meraz M. A., White J. M., Lampe P. A., Riley J. K., Arthur C. D. Disruption of the Jak1 gene demonstrates obligatory and nonredundant roles of the Jaks in cytokine-induced biologic responses. Cell. 93:1998;373-383.
19. Neubauer H., Cumano A., Mueller M., Wu H., Huffstadt U., Pfeffer K. Jak2 deficiency defines an essential developmental checkpoint in definitive hematopoiesis. Cell. 93:1998;397-409.
20. Parganas E., Wang D., Stravopidis D., Topham D., Marine J.-C., Teglund S. Jak2 is essential for signaling through a variety of cytokine receptors. Cell. 93:1998;385-395.
21. Leonard W. J. The moleuclar basis of X-linked sever combined immunodeficiency: Defective cytokine receptor signaling. Annu. Rev. Med. 47:1996;229-239.
22. Park S. Y., Saijo K., Takahashi T., Osawa M., Arase H., Hirayama N. Developmental defects of lymphoid cells in Jak3 kinase-deficient mice. Immunity. 3:1995;771-782.
23. Thomis D. C., Gurniak C. B., Tivol E., Sharpe A. H., Berg L. J. Defects in B lymphocyte maturation and T lymphocyte activation in mice lacking Jak3. Science. 270:1995;794-797.
24. Nosaka T., vanDeursen J. M., Tripp R. A., Thierfelder W. E., Witthuhn B. A., McMickle A. P., Doherty P. C., Grosveld G. C., Ihle J. N. Defective lymphoid development in mice lacking Jak3. Science. 270:1995;800-802.
25. Meraz M. A., White J. M., Sheehan K. C., Bach E. A., Rodig S. J., Dighe A. S. Targeted disruption of the Stat1 gene in mice reveals unexpected physiological specificity in the JAK-STAT pathway. Cell. 84:1996;431-442.
26. Durbin J. E., Hackenmiller R., Simon M. C., Levy D. E. Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease. Cell. 84:1996;443-450.
27. Park, C, Li, S, and, Schindler, C. 1999, Stat2 null mice are deficient in response to both type I and II interferons. Submitted for publication.
28. Takeda K., Noguchi K., Shi W., Tanaka T., Matsumoto M., Yoshida N., Kishimoto T., Akira S. Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality. Proc. Natl. Acad. Sci. USA. 94:1997;3801-3804.
29. Takeda K., Clausen B. E., Kaisho T., Tsujimura T., Terada N., Förster I., Akira S. Enhanced Th1 activity and development of chornic enteroclolitis in mice devoid of Stat3 in macrophages and neutrophils. Immunity. 10:1999;39-49.
30. Takeda K., Kaisho T., Yoshida N., Takeda J., Kishimoto T., Akira S. Stat3 activation is responsible for IL-6-dependent T cell proliferation through preventing apoptosis: Generation and characterization of T cell-specific Stat3-deficient mice. J. Immunol. 161:1998;4652-4660.
31. Thierfelder W. E., vanDeursen J. M., Yamamoto K., Tripp R. A., Sarawar S. R., Carson R. T. Requirement for Stat4 in interleukin-12 mediated response of natural killer and T cells. Nature. 382:1996;171-174.
32. Kaplan M. H., Sun Y.-L., Hoey T., Grusby M. J. Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice. Nature. 382:1996;174-177.
33. Liu X., Robinson G. W., Wagner K. U., Garrett L., Wynshaw-Boris A., Hennighausen L. Stat5a is mandatory for adult mammary gland development and lactogenesis. Genes Dev. 11:1997;179-186.
34. Udy G. B., Towers R. P., Snell R. G., Wilkins R. J., Park S. H., Ram P. A., Waxman D. J., Davey H. W. Requirement of Stat5b for sexual dimorphism of body growth rates and liver gene expression. Proc. Natl. Acad. Sci. USA. 94:1997;7239-7244.
35. Teglund S., McKay C., Schuetz E., VanDeursen J. M., Stravopodis D., Wang D. Stat5a and Stat5b proteins have essential roles and nonessential, or redundant, roles in cytokine responses. Cell. 93:1998;841-850.
36. Moriggl R., Topham D. J., Teglund S., Sexl V., McKay C., Wang D. Stat5 is required for IL-2-induced cell cycle progression of peripheral T cells. Immunity. 10:1999;249-259.
37. Socolovsky M., Fallon A. E., Wang S., Brugnara C., Lodish H. F. Fetal anemia and apoptosis of red cell progenitors in Stat5a -/- 5b -/- mice: A direct role for Stat5 in Bcl-XL induction. Cell. 98:1999;181-191.
38. Takeda K., Tanaka T., Shi W., Matsumoto M., Minami M., Kashiwamura S. Essential role of Stat6 in IL-4 signalling. Nature. 380:1996;627-630.
39. Shimoda K., vanDeursen J., Sangster M. Y., Sarawar S. R., Carson R. T., Tripp R. A. Lack of IL-4 induces Th2 response in IgE class switching mice with disrupted Stat6 gene. Nature. 380:1996;630-633.
40. Kaplan M. H., Schindler U., Smiley S. T., Grusby M. J. Stat6 is required for mediating responses to IL-4 and for the development of Th2 cells. Immunity. 4:1996;313-319.
41. Kawata T., Shevchenko A., Fukuzawa M., Jermyn K. A., Totty N. F., Zhukovskaya N. V., Steriling A. E., Mann M., Williams J. G. SH2 signaling in a lower eukaryote: A STAT protein that regulates stalk cell differentiation in Dictyostelium. Cell. 89:1997;909-916.
42. Dearolf C. R. JAKs and STATs in invertebrate model organisms. CMLS, Cell. Mol. Life Sci. 55:1999;1578-1584.
43. Hou X. S., Perrimon N. The Jak-STAT pathway in Drosophila. Trends Genet. 13:1997;105-110.
44. Conway G., Margoliath A., Wong-Madden S., Roberts R. J., GIlbert W. Jak1 kinase is required for cell migrations and anterior specification in zebrafish. Proc. Natl. Acad. Sci. USA. 94:1997;3082-3087.
45. Adler K., Gerisch G., vonHugo U., Lupas A., Schweiter A. Classification of tyrosine kinases form Dictyostelium discoideum with two distinct, complete or incomplete catalytic domains. FEBS Lett. 395:1996;286-292.
46. Zeidler M. P., Perrimon N., Strutt D. I. Polarity determination in the Drosophila eye: A novel role for unpaired and JAK/STAT signaling. Genes Dev. 13:1999;1342-1353.
47. Araki T., Gamper M., Early A., Fukuzawa M., Abe T., Kawata T., Kim E., Firtel R. A., Williams J. G. Developmentally and spatially regulated activation of a Dictyostelium STAT protein by a serpentine receptor. EMBO J. 17:1998;4018-4028.
48. Ali M. S., Sayeski P. P., Dirksen L. B., Hayzer D. J., Marrero M. B., Bernstein K. E. Dependence on the motif YIPP for the physical association of Jak2 kinase with the intracellualr carboxyl tail of the angiotensin II AT1 receptor. J. Biol. Chem. 272:1997;23382-23388.
49. Hilton D. J. Negative regulators of cytokine signal transduction. CMLS, Cell. Mol. Life Sci. 55:1999;1568-1577.
50. Klingmüller U., Lorenz U., Cantley L. C., Neel B. G., Lodish H. F. Specefic recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of Jak2 and termination of proliferative signals. Cell. 80:1995;729-738.
51. Starr R., Hilton D. J. Negative regulation of the JAK/STAT pathway. BioEssays. 21:1999;47-52.
52. Hilton D. J., Richardson R. T., Alexander W. S., Viney E. M., Wilson T. A., Sprigg N. S. Twenty proteins containing a C-terminal SOCS box from five structural classes. Proc. Natl. Acad. Sci. USA. 95:1998;114-119.
53. Naka T., Matsumoto T., Narazaki M., Fujimoto M., Morita Y., Ohsawa Y. Accelerated apoptosis of lymphocytes by augmented induction of Bax in SSI-1 (STAT-induced STAT inhibitor-1) deficient mice. Proc. Natl. Acad. Sci. USA. 95:1998;15577-15582.
54. Starr R., Metcalf D., Elefanty A. G., Brysha M., Willson T. A., Nicola N. A., Hilton D. J., Alexander W. S. Liver degeneration and lymphoid deficiencies in mice lacking suppressor of cytokine signaling-1. Proc. Natl. Acad. Sci. USA. 95:1998;14395-14399.
55. Nicola, N. A, Nicholson, S, Metcalf, D, Zhang, J.-G, Baca, M, Farely, A, et al., 1999. Negative regulation of cytokine signaling by SOCS proteins, Abstr. LXIV Cold Spring Harbor Symp. Quant. Biol.
56. Kamura T., Sato S., Haque D., Liu L., Kaelin W. G., Conaway R. C., Conaway J. W. The Elongin BC complex interacts with the conserved SOCS-box motif present in members of the SOCS, ras, WD-40 repeat, and ankyrin repeat families. Genes Dev. 12:1998;3872-3881.
57. Konietzko U., Kauselmann G., Scafidi J., Staubli U., Mikkers H., Berns A., Schweizer M., Waltereit R., Kuhl D. Pim kinase expression is induced by LTP stimulation and required for the consolidation of enduring LTP. EMBO J. 18:1999;3359-3369.
58. Kovarik P., Decker T. Transcription factor activity of STAT proteins: Structural requirements and regulation by phosphorylation and interacting proteins. CMLS, Cell. Mol. Life Sci. 55:1999;1535-1546.
59. Schindler C. STATs as activators of apoptosis. Trends Cell Biol. 8:1998;97-98.
60. Zhang X., Blenis J., Li H.-C., Schindler C., Chen-Kiang S. Requirement of serine phosphorylation for formation of STAT-promoter complexes. Science. 267:1995;1990-1994.
61. Wen Z., Zhong Z., Darnell J. E. Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell. 82:1995;241-250.
62. WAF1/CIP1 mediated by Stat1. Science. 272:1996;719-722.
63. Garcia R., Jove R. Activation of STAT transcription factors in oncogenic tyrosine kinase signaling. J. Biomed. Sci. 5:1998;79-85.
64. Bromberg J. F., Wrzeszczynska M. H., Devgan G., Zhao Y., Pestell R. G., Albanese C., Darnell J. E. Stat3 as an Oncogene. Cell. 98:1999;295-303.
65. Kiuchi N., Nakajima K., Ichiba M., Fukada T., Narimatsu M., Mizuno K., Hibi M., Hirano T. STAT3 is required for the gp130-mediated full activation of the c-myc gene. J. Exp. Med. 189:1999;63-73.
66. Catlett-Falcone R., Landowski T. H., Oshiro M. M., Turkson J., Levitzki A., Savino R. Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells. Immunity. 10:1999;105-115.
67. Kumar A., Commane M., Flickinger T. W., Horvarth C. M., Stark G. R. Defective TNF-α induced apoptosis in Stat1 null cells due to low constitutive levels of caspases. Science. 278:1997;1630-1632.
68. Taniguchi T., Tanaka N., Taki S., Ogasawara K., Hida S., Sato M., Takaoka A., Hata N. Regulation of the interferons and immune systems by the IRF family of transcription factos. Abstr. LXIV Cold Spring Harbor Symp. Quant. Biol. 1999.
69. Matsuyama T., Kimura T., Kitagawa M., Pfeffer K., Kawakami T., Watanabe N. Targeted disruption of IRF-1 and IRF-2 results in abnormal type I IFN gene induction and abarrant lymphocyte development. Cell. 75:1993;83-97.